// App-Quantinova.ai

604 : Regional nodal irradiation after breast conserving surgery for HER2-positive breast cancer: Results of a sub analysis from the ALTTO trial.

Researchers

Presenter

  • Isabelle Gingras

Principal Investigators

  • Eileen McCormick Holmes

  • Evandro De Azambuja

  • David H. A. Nguyen

  • Miguel A. Izquierdo

  • Jo Anne Zujewski

  • Moshe J. Inbar

  • Bjorn Naume

  • Gianluca Tomasello

  • Michael Gnant

  • Alvaro Moreno-Aspitia

  • Martine J. Piccart-Gebhart

  • Hatem A. Azim

Medical Centers

  • Montreal University, Montreal, QC, Canada

  • Frontier Science (Scotland) Ltd, Kincraig, United Kingdom

  • Institut Jules Bordet, Universite libre de Bruxelles, Brussels, Belgium

  • Hopital Maisonneuve-Rosemont, Montreal, QC, Canada

  • Novartis AG, Basel, Switzerland

  • National Human Genome Research Institute, National Institutes of Health, Bethesda, MD

  • Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel

  • Oslo University Hospital, Oslo, Norway

  • ASST di Cremona - Ospedale di Cremona, Cremona, Italy

  • Medical University of Vienna, Vienna, Austria

  • Mayo Clinic, Jacksonville, FL

  • Institut Jules Bordet, Universite libre de Bruxelles, Brussels, Belgium

  • Institute Jules Bordet, Brussels, Belgium

Locations

  • Canada

  • Norway

  • Italy

  • Austria

  • United Kingdom

  • Switzerland

  • United States

  • Israel

  • Belgium

Companies

  • Frontier Science (Sc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved